Ankle-foot Orthoses for Night Splinting in Children With CP: Impact on Passive Stiffness in Plantarflexors Muscles

NCT ID: NCT03686644

Last Updated: 2022-07-22

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

WITHDRAWN

Clinical Phase

NA

Study Classification

INTERVENTIONAL

Study Start Date

2018-10-16

Study Completion Date

2018-10-16

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Children with cerebral palsy present early in the childhood altered muscular properties, characterized by short muscle belly length and increased stiffness which contribute to contracture and limiting joint range of motion. In order to prevent equinus deformity, ankle foot orthoses for night splinting are usually used in children with spastic Cerebral Palsy (CP). However, there's a lack of proof about efficacy by using this modality of treatment. Moreover, impact on quality of life for children and families, cost for society were high.

Principal purpose of this study was to assess impact of night splint ankle foot orthoses on passive stiffness in plantarflexors muscles in children with CP.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Children with cerebral palsy present early in the childhood altered muscular properties, characterized by short muscle belly length and increased stiffness which contribute to contracture and limiting joint range of motion. In order to prevent equinus deformity, ankle foot orthoses for night splinting are usually used in children with spastic CP. However, there's a lack of proof about efficacy by using this modality of treatment. Moreover, impact on quality of life for children and families, cost for society were high.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Cerebral Palsy

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Children with Cerebral Palsy

Children with Cerebral Palsy (CP) will be included. They will have to wearing of night splint ankle foot orthoses (phase A) and then no wearing of night splint ankle foot orthoses (phase B). The phases A and B will be repeated twice. In more, they will have an ultrasound, isokinetic dynamometer and measure of quality of night sleeping.

Group Type EXPERIMENTAL

Wearing of night splint ankle foot orthoses (phase A)

Intervention Type PROCEDURE

Children wearing of night splint ankle foot orthoses during 6, 7 or 8 days according to the position of inclusion.

An ultrasound of the leg muscles will be realized every morning after removing night splint.

An isokinetic dynamometer will be realize at the beginning of the study and at the end of each phase.

measure of quality of night sleeping will be measured by Visual Analog Scale (VAS) results.

No wearing of night splint ankle foot orthoses (phase B)

Intervention Type PROCEDURE

Children no wearing of night splint ankle foot orthoses during 6, 7 or 8 days according to the position of inclusion.

An ultrasound of the leg muscles will be realized every morning after removing night splint.

An isokinetic dynamometer will be realize at the beginning of the study and at the end of each phase.

measure of quality of night sleeping will be measured by Visual Analog Scale (VAS) results.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Wearing of night splint ankle foot orthoses (phase A)

Children wearing of night splint ankle foot orthoses during 6, 7 or 8 days according to the position of inclusion.

An ultrasound of the leg muscles will be realized every morning after removing night splint.

An isokinetic dynamometer will be realize at the beginning of the study and at the end of each phase.

measure of quality of night sleeping will be measured by Visual Analog Scale (VAS) results.

Intervention Type PROCEDURE

No wearing of night splint ankle foot orthoses (phase B)

Children no wearing of night splint ankle foot orthoses during 6, 7 or 8 days according to the position of inclusion.

An ultrasound of the leg muscles will be realized every morning after removing night splint.

An isokinetic dynamometer will be realize at the beginning of the study and at the end of each phase.

measure of quality of night sleeping will be measured by Visual Analog Scale (VAS) results.

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Children diagnosed spastic cerebral palsy
* Children wearing night splint ankle foot orthoses all night long during 1 week minimum
* Children with a level of spasticity in the gastrocnemius muscle greater than or equal to X1, VII, on the Tardieu scale and 2 on the Ashworth scale.
* Children able to understand and respect the simple instructions of the study
* Children and parents who received informed information about the study and who co-signed, with the investigator, a consent to participate in the study.

Exclusion Criteria

* Children who do not tolerate ankle foot orthoses all night long.
* Children who had botulinum injection in gastrocnemius or soleus muscles during last three months.
* Children benefiting from an injection of botulinum toxin or the setting up of new equipment during the protocol.
* Children who do not tolerate ankle foot orthoses all night long.
* Children having benefited from plaster lengthening for less than three months.
Minimum Eligible Age

8 Years

Maximum Eligible Age

16 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Centre Hospitalier Universitaire de Saint Etienne

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Vincent GAUTHERON, MD PhD

Role: PRINCIPAL_INVESTIGATOR

CHU de Saint Etienne

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2018-A01082-53

Identifier Type: OTHER

Identifier Source: secondary_id

18CH070

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.